BioVie, Inc.
BIVI • NASDAQ
BioVie, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Cuong Viet Do, with a market cap of $10.3M.
CEOCuong Viet Do
Next Earnings
Upcoming earnings announcement for BioVie, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q3 2026
EPS Estimate
-$0.73
Earnings History
Past 12 earnings reports for BioVie, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | Q2 2026 | -$0.77Est: -$0.81 | +4.9% | - | — |  10-Q |
| Nov 10, 2025 | Q1 2026 | -$0.98Est: -$0.79 | -24.1% | - | — | 10-Q |
| Aug 15, 2025 | Q4 2025 | -$1.42Est: -$4.40 | +67.7% | - | — | 10-K |
| May 12, 2025 | Q3 2025 | -$0.15Est: -$0.32 | +53.1% | - | — | 10-Q |
| Feb 11, 2025 | Q2 2025 | -$0.46 | — | - | — | 10-Q |
| Nov 13, 2024 | Q1 2025 | -$0.70 | — | - | — | 10-Q |
| Sep 30, 2024 | Q4 2024 | -$0.30Est: -$3.40 | +91.2% | - | — | 10-K |
| May 14, 2024 | Q3 2024 | -$2.00Est: -$3.30 | +39.4% | - | — | 10-Q |
| Feb 13, 2024 | Q2 2024 | -$2.20Est: -$3.20 | +31.3% | - | — | 10-Q |
| Nov 8, 2023 | Q1 2024 | -$2.90Est: -$3.10 | +6.5% | - | — | — |
| Aug 16, 2023 | Q4 2023 | -$2.30 | — | - | — | 10-K |
| May 12, 2023 | Q3 2023 | -$4.30Est: -$3.50 | -22.9% | - | — | — |